TRACE
Trace a source
tape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advicetape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advice
publisheddirectional thesisLONGyoutubenot an explicit trade

MEDP directional thesis

A pure-play clinical-trial CRO climbs as AI multiplies drug candidates and the work of running and approving trials becomes the real chokepoint, with the stock already beaten down on the opposite fear.

$428.03entry snapshot
pendingcurrent snapshot
— pendingsince mention
“I actually worry more about the drug approval process where I think AI models are going to greatly accelerate the rate at which we discover drugs and just the pipeline will get jammed up, like the pipeline will not be prepared to, like, process all of the stuff that's going through it.”
102:28claim_id mcl_f4a21cc333a899198copen evidence ↗
Classification directional thesis

Human-reviewed public claim.

Evidence span 102:28

Evidence URL, source timestamp, and excerpt are attached to this permanent claim page.

Correction path available

Creators or reviewers can request reclassification, context, or entity corrections without erasing the source record.

Machine-readable claim
{
  "version": "market-claims.v1",
  "claim": {
    "id": "mcl_f4a21cc333a899198c",
    "url": "/trace/claims/mcl_f4a21cc333a899198c",
    "status": "PUBLISHED",
    "claimType": "DIRECTIONAL_THESIS",
    "direction": "LONG",
    "claimText": "A pure-play clinical-trial CRO climbs as AI multiplies drug candidates and the work of running and approving trials becomes the real chokepoint, with the stock already beaten down on the opposite fear.",
    "confidence": 0.72,
    "expert": {
      "slug": "dwarkesh-sp",
      "displayName": "Dwarkesh Podcast",
      "kind": "PERSON",
      "status": "UNCLAIMED",
      "avatarUrl": "/api/avatars/c3263695-7",
      "url": "/trace/experts/dwarkesh-sp",
      "claimed": false
    },
    "primaryEntity": {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "MEDP",
      "name": "MEDP",
      "exchange": null,
      "confidence": 0.78
    },
    "evidence": {
      "evidenceUrl": "https://www.youtube.com/watch?v=n1E9IZfvGMA&t=6148s",
      "sourceUrl": "https://youtube.com/watch?v=n1E9IZfvGMA",
      "timecode": "102:28",
      "startMs": 6148000,
      "endMs": null,
      "excerpt": "I actually worry more about the drug approval process where I think AI models are going to greatly accelerate the rate at which we discover drugs and just the pipeline will get jammed up, like the pipeline will not be prepared to, like, process all of the stuff that's going through it."
    },
    "performance": {
      "entryPrice": 428.0299987793,
      "currentPrice": null,
      "returnPct": null,
      "relativePct": null,
      "method": "PASTE_AUTHOR_PRICE"
    },
    "resolutionStatus": "OPEN",
    "ambiguityNotes": null,
    "horizon": null,
    "isExplicitTrade": false,
    "notFinancialAdvice": true,
    "disclaimer": "AISO tracks public statements, not verified portfolio positions. This is not financial advice."
  },
  "expert": {
    "slug": "dwarkesh-sp",
    "displayName": "Dwarkesh Podcast",
    "kind": "PERSON",
    "status": "UNCLAIMED",
    "avatarUrl": "/api/avatars/c3263695-7",
    "url": "/trace/experts/dwarkesh-sp",
    "claimed": false
  },
  "source": {
    "platform": "YOUTUBE",
    "title": "Dario Amodei — “We are near the end of the exponential”",
    "sourceUrl": "https://youtube.com/watch?v=n1E9IZfvGMA",
    "publishedAt": "2026-02-13T17:11:03.000Z"
  },
  "evidence": {
    "evidenceUrl": "https://www.youtube.com/watch?v=n1E9IZfvGMA&t=6148s",
    "sourceUrl": "https://youtube.com/watch?v=n1E9IZfvGMA",
    "timecode": "102:28",
    "startMs": 6148000,
    "endMs": null,
    "excerpt": "I actually worry more about the drug approval process where I think AI models are going to greatly accelerate the rate at which we discover drugs and just the pipeline will get jammed up, like the pipeline will not be prepared to, like, process all of the stuff that's going through it.",
    "quote": "I actually worry more about the drug approval process where I think AI models are going to greatly accelerate the rate at which we discover drugs and just the pipeline will get jammed up, like the pipeline will not be prepared to, like, process all of the stuff that's going through it.",
    "speaker": "Dario Amodei"
  },
  "entities": [
    {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "MEDP",
      "name": "MEDP",
      "exchange": null,
      "confidence": 0.78
    }
  ],
  "marketData": {
    "entry": {
      "price": 428.0299987793,
      "currency": "USD",
      "observedAt": "2026-02-13T17:11:03.000Z",
      "method": "PASTE_AUTHOR_PRICE"
    },
    "current": null,
    "returnPct": null
  },
  "snapshots": [
    {
      "kind": "ENTRY",
      "symbol": "MEDP",
      "assetClass": "EQUITY",
      "price": 428.0299987793,
      "probability": null,
      "currency": "USD",
      "provider": "paste.trade",
      "providerSymbol": "MEDP",
      "observedAt": "2026-02-13T17:11:03.000Z",
      "method": "PASTE_AUTHOR_PRICE",
      "returnPct": null,
      "relativePct": null
    }
  ]
}

AISO Market Calls classifies public statements from public sources. A classification such as long thesis, short thesis, or explicit call describes the content of the public statement and does not prove that the speaker actually entered, exited, or held a position. Market performance shown is calculated from public market data around the source publication or timestamp. It is not investment advice.